Skip to main content
Clinical Trials/ITMCTR1900002649
ITMCTR1900002649
Recruiting
未知

Establishment of a strategy system for the treatment of prostate cancer with Chinese medicine and its superiority research program

Guangdong Provincial Hospital of Chinese Medicine0 sitesTBD
Conditionsprostate cancer

Overview

Phase
未知
Intervention
Not specified
Conditions
prostate cancer
Sponsor
Guangdong Provincial Hospital of Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational study
Sex
Male

Investigators

Sponsor
Guangdong Provincial Hospital of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • (1\) Comply with the diagnostic criteria for prostate adenocarcinoma and give endocrine therapy;
  • (2\) Serum testosterone \<50 ng / dl (1\.7 nmol / L);
  • (3\) The physical strength of the study subjects is normal, and the karnofsky score exceeds 60 points, and is expected to survive for more than half a year;
  • (4\) Patient compliance is good and follow\-up studies are possible;
  • (5\) Understand and sign the informed consent form.
  • The above five conditions must be met at the same time.

Exclusion Criteria

  • (1\) Patients with serious complications of prostate cancer;
  • (2\) Allergic to endocrine therapy drugs;
  • (3\) At the same time, it has obvious heart, brain and liver diseases;
  • (4\) Patients with primary malignant tumors of organs other than prostate cancer;
  • (5\) It is the end stage of the tumor, multiple organ failure.

Outcomes

Primary Outcomes

Not specified

Similar Trials